A young man in West Virginia receives a vaccine while overlooking the West Virginia Capitol building in Riggleman Hall.
Stephen Senner | LightRocket | Getty Images
The Centers for Disease Control and Prevention said Thursday that The number of heart attack cases among 16 to 24 year olds was higher than expected. after they received the Pfizer vaccine or the COVID-19 vaccine of Pfizer’s for the second time, the Centers for Disease Control and Prevention said Thursday. by preliminary Information from the Vaccine Safety Monitoring System
275 cases of myocardial infarction or pericarditis, an inflammatory condition associated with the heart, were reported in people aged 16 to 24 as of May 31, according to a CDC presentation prepared for a panel meeting at Consult the Food and Drug Administration on Thursday.
The FDA Advisory Committee on Vaccines and Related Biological Products is holding a meeting to discuss the use of the COVID-19 vaccine. in children under 6 months
The expected number of patients is between 10 and 102 according to the CDC.
The CDC has reported a total of 475 cases of myocardial infarction or pericarditis among those aged 30 and over. Most of the patients who were hospitalized, or 81% of patients, fully recovered from their system. As of May 31, 15 patients are still hospitalized, with three of them in critical condition.
The CDC states that most cases occur in men. and the median time to onset was two to three days.
The CDC’s vaccine safety group said last month it was looking at heart conditions in people. ‘Quite a few’ have been vaccinated against COVID.
Most such cases occur in adolescence and young adulthood. And it usually occurs within four days of receiving the shot, the CDC said at the time. This condition is more common in men. and most of the patients are usually mild. Even if the staff is following the patient
The CDC is coordinating an investigation with the FDA, which last month authorized the vaccine. Pfizer-BioNTech For teens ages 12 to 15
“We still don’t know if this has anything to do with real vaccines,” Dr Peter Marks, director of the FDA’s Center for Biological Assessment and Research, said during a virtual Q&A on Day 27. May, he added, “of the reported cases. “Not very serious lasts for a day or two” and usually occurs after the second dose.
This is an evolving story. Please come back and check for updates.